A Phase 1b, Randomized, Double-Blind, Placebo-Controlled

Project: Research project

Project Details

Description

A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients with Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
StatusFinished
Effective start/end date1/31/151/31/17

Funding

  • NIVALIS THERAPEUTICS, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.